thiazolidinedione antidiabetic
thiazolidinedione antidiabetic
antidiabetic activity, including functional potency at peroxisome proliferator thiazolidinedione antidiabetic significantly reduced plasma glucose (33%, p<0.01) and plasma triglycelide levels (43%, p<0.01) even at a dosage of 0.001% in diet. Pharmacokinetic analyses of 25 are also reported.A novel series of oxyiminoacetic acid derivatives were synthesized in an effort to develop a potent antidiabetic agent, [...]